J u l y 2 0 1 8 • O U T PA T I E N TS U R G E R Y. N E T • 8 9
A new monofocal IOL
With all the technological advances in torics and multifo-
cals, monofocal IOLs haven't received much attention lately.
Bausch & Lomb is hoping that will change with the
enVista monofocal IOL. The company claims
its new lens enjoys several advantages over
competing products:
• The lens incorporates what the com-
pany calls "advanced, aberration-free
optics," with uniform power throughout.
Clinically, the company says that means
better visual results. The lens performs
well even if it's decentered, and it pro-
vides excellent depth of field, image quali-
ty and contrast sensitivity.
• The company says there are no "glisten-
ings" or edge glare, complications that have
occurred with other IOLs.
• The material is 16 times harder than traditional hydrophobic IOLs,
making it hard to scratch.
• The haptics provide exceptional contact with the capsular bag,
promising superior stability.
"I'm in a small town. If something is going to go wrong with an IOL
15 years from now, that's a big, big deal to me," says Dr. Mahootchi.
He likes the enVista lens material for that reason — it's stable, and
in the unlikely event that a patient requires an air or gas bubble for a
retinal procedure, the lens doesn't opacify. "I recommend it for my
neighbors," says Dr. Mahootchi. "Previously, the disadvantage was
that it unfolds a little slowly. Now it unfolds much quicker."
• Bausch & Lomb's enVista
MX60E monofocal IOL.
